Company news
Fosun International Limited (HKEX:656) news
Fosun International Limited news releases on 6ix. Latest, Sep 21, 2026: Fosun International : CLUB MED INAUGURATES ITS FIRST RESORT IN SOUTH AFRICA…
Press releases & updates
Fosun International : CLUB MED INAUGURATES ITS FIRST RESORT IN SOUTH AFRICA, PIONEERING A NEW BEACH & SAFARI EXPERIENCE
September 21, 2026
ClubMed Lifestyle Group Advances Global Expansion Through Industry Collaboration and AI Application
September 8, 2026
Fosun International : Hang Seng Sustainability Rating Climbs to AA+, Setting a New Record
September 7, 2026
Fosun International's Hang Seng Sustainability Rating Climbs to AA+, Setting a New Record
September 7, 2026
Fosun International Holds 2026 Interim Results Presentation: Unlocking Core Pathways, Accelerating Growth in Industries where we Excel
August 31, 2026
Fosun International : Henlius’ Serplulimab Approved for Perioperative Gastric Cancer, Pioneering a Chemotherapy-Sparring Adjuvant Approach
June 9, 2026
Fosun International : Henlius' Pertuzumab Approved in China, Solidifying Breast Cancer Strategy as the First China-US-EU Approved Chinese Trastuzumab-Pertuzumab Combination
May 28, 2026
Fosun International : Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer’s Disease
May 14, 2026
Fosun International : Henlius’ HLX43 (anti-PD-L1 ADC) Receives PMDA’s Acknowledge to Initiate Global Phase 2/3 Trial in sqNSCLC
May 8, 2026
Fosun International : ESG Report 2025
April 28, 2026
Fosun International: Total Revenue in 2025 Reaches RMB173.43 Billion, with Overseas Revenue Accounting for 54.7%，Aiming to Achieve“RMB10 Billion in Profit”
March 30, 2026
Fosun International : and HSBC China Sign Strategic Cooperation Agreement
March 13, 2026
Fosun Navigates Cyclical Volatility and Clears Risks as Management Reaffirms RMB10 Bn Profit Target for Next 3 to 5 Yrs
March 12, 2026
Fosun International: One-Off Non-Cash Impairment Provisions for Certain Non-Core Businesses, Core Industries Maintain Sound Development Momentum
March 9, 2026
Fosun International : Receives “Certificate of Excellence in Environmental, Social and Governance Reporting” from Hong Kong Management Association
February 26, 2026
Fosun International : Honored as “ESG Leading Enterprise” by Bloomberg Businessweek/Chinese Edition
November 21, 2025
Fosun International : Henlius Completes Patient Enrolment in the U.S. Bridging Study of Serplulimab in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
October 23, 2025
Fosun International : Signs Strategic Cooperation Agreement with BNP Paribas
October 13, 2025
Fosun International : S&P Global CSA Score Rises to 72, Retains Industry Lead
October 9, 2025
Fosun International : Achieves AA- in HSI ESG Rating for Third Consecutive Year, Marks Sixth Year as Constituent of Hang Seng Corporate Sustainability Benchmark Index
September 14, 2025
Fosun International : Holds Signing Ceremony for USD910 Million Equivalent Syndicated Loan, Underscoring Global Market Confidence in its Future Development
September 10, 2025
Fosun International : Pharma Gains Exclusive Rights for Accro's Novel Small-Molecule Drug Candidate AC-201 in Greater China
September 1, 2025
Fosun International : Hosts 2025 Interim Results Presentation, Reaffirms Confidence in Future Development Driven by Innovation and Globalization
August 29, 2025